Levin Capital Strategies’s Standard BioTools LAB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,672	Closed	-$26.7K	–	300
2023 Q1	$26.7K	Hold	13,672	–	–	﹤0.01%	233
2022 Q4	$16K	Hold	13,672	–	–	﹤0.01%	235
2022 Q3	$15K	Hold	13,672	–	–	﹤0.01%	229
2022 Q2	$22K	Hold	13,672	–	–	﹤0.01%	257
2022 Q1	$49K	Hold	13,672	–	–	﹤0.01%	299
2021 Q4	$54K	Hold	13,672	–	–	0.01%	319
2021 Q3	$90K	Hold	13,672	–	–	0.01%	324
2021 Q2	$84K	Hold	13,672	–	–	0.01%	348
2021 Q1	$62K	Sell	13,672 -28,687	-68%	-$158K	0.01%	329
2020 Q4	$254K	Sell	42,359 -16,383	-28%	-$108K	0.03%	226
2020 Q3	$436K	Sell	58,742 -130,724	-69%	-$902K	0.06%	147
2020 Q2	$760K	Buy	189,466 +26,878	+17%	+$93.6K	0.1%	89
2020 Q1	$413K	Buy	162,588 +21,000	+15%	+$69K	0.07%	96
2019 Q4	$493K	Sell	141,588 -11,841	-8%	-$41.7K	0.05%	116
2019 Q3	$710K	Sell	153,429 -21,000	-12%	-$165K	0.08%	101
2019 Q2	$2.15M	Sell	174,429 -6,427	-4%	-$81.9K	0.21%	66
2019 Q1	$2.4M	Sell	180,856 -9,386,212	-98%	-$98.9M	0.27%	55
2018 Q4	$82.5M	Sell	9,567,068 -634,723	-6%	-$4.94M	1.82%	21
2018 Q3	$76.4M	Sell	10,201,791 -6,531	-0.1%	-$46.4K	1.31%	24
2018 Q2	$60.8M	Buy	10,208,322 +492,914	+5%	+$2.81M	1.05%	30
2018 Q1	$56.7M	Buy	9,715,408 +548,338	+6%	+$3.6M	1.03%	30
2017 Q4	$54M	Buy	9,167,070 +463,310	+5%	+$2.54M	0.91%	33
2017 Q3	$43.9M	Buy	8,703,760 +2,948,007	+51%	+$12.4M	0.74%	34
2017 Q2	$23.3M	Hold	5,755,753	–	–	0.41%	43
2017 Q1	$32.8M	Hold	5,755,753	–	–	0.58%	40
2016 Q4	$41.9M	Buy	5,755,753 +1,370,490	+31%	+$8.61M	0.72%	38
2016 Q3	$35.1K	Buy	4,385,263 +789,688	+22%	+$7.25M	0.52%	40
2016 Q2	$32.5M	Buy	3,595,575 +1,505,320	+72%	+$14.1M	0.59%	40
2016 Q1	$16.9M	Buy	+2,090,255	New	+$15.1M	0.31%	57